PRRS vaccine discovery for swine
PRRS vaccine, an unexpected scientific discovery. Our team developed the first vaccine against Porcine Reproductive and Respiratory Syndrome in pigs.
Search
Animal Health Partnering Interests Oral Health May 2024 CORP
Growing with us
We recognize the benefits of learning and have created an environment where life-long learning and personal growth are encouraged for all employees.
10 tips cat friendly veterinary clinics
Here are 10 simple steps you can take to make feline patients feel at ease at your practice.
About Us
About us
New cancer therapeutics collaboration with 3T Bio
Boehringer Ingelheim and 3T Biosciences collaborate to discover and develop next-generation cancer therapies to address high unmet patient needs
Julia Sonnermann
Julia Sonnermann on transforming lives for generations
FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs
Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program
Prof. Eric Haaksma
Prof. Eric Haaksma on transforming lives for generations
Patricia Rangel
Patricia Rangel on transforming lives for generations
Giving Life a Chance
The Angels initiative honours stroke units and the everyday heroes making a difference for stroke patients
Boehringer Ingelheim announces appointments Board of Managing Directors
Boehringer Ingelheim announces appointments Board of Managing Directors
Zucchini Ravioli
Fish Pie
This comforting fish pie from Taking Cancer on Through Flavour is full of protein to keep you feeling satisfied for longer[node:body][node:title]
Making Every Second Count
The Angels initiative honours emergency response teams making a difference for stroke patients
Saving Lives
The Angels initiative honours nurses saving lives one grandpa at a time
Boehringer Ingelheim strong growth pipeline acceleration 2023
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Boehringer unveils first global sustainability publication
Boehringer Ingelheim unveils its first global sustainability publication ‘Imagine’
Imagine: The impact of volunteering activities on elderly well-being
How our employees contribute to elderly well-being with creative volunteering activities in Australia, South Korea, Southeast Asia, and New Zealand.
Phase 1 start for novel triple agonist obesity treatment
Boehringer and Gubra announce Phase 1 study of BI 3034701, a long-acting, next generation, first-in-class triple agonist peptide for obesity treatment
Digital solutions save lives
Michael Schmelmer explains how digital solutions shape the future of Boehringer Ingelheim and the entire healthcare industry.
Nagoya Protocol
At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do.
Mexico rabies free dog vaccination campaigns
Mexico: a champion in the fight against rabies. The first country in the world to be declared free from dog-transmitted rabies.
Chronic kidney disease in cats
Detect and manage chronic kidney disease and high blood pressure in cats
Sharing knowledge from our medical device development
Why do we share some of our work beyond Boehringer for free?